A detailed history of Great Lakes Advisors, LLC transactions in Axsome Therapeutics, Inc. stock. As of the latest transaction made, Great Lakes Advisors, LLC holds 16,728 shares of AXSM stock, worth $1.63 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
16,728
Previous 12,141 37.78%
Holding current value
$1.63 Million
Previous $977,000 53.84%
% of portfolio
0.01%
Previous 0.01%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 04, 2024

BUY
$78.93 - $95.84 $362,051 - $439,618
4,587 Added 37.78%
16,728 $1.5 Million
Q2 2024

Aug 05, 2024

BUY
$65.72 - $80.5 $797,906 - $977,350
12,141 New
12,141 $977,000

Others Institutions Holding AXSM

About Axsome Therapeutics, Inc.


  • Ticker AXSM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 42,878,000
  • Market Cap $4.18B
  • Description
  • Axsome Therapeutics, Inc., a biopharmaceutical company, engages in the development of novel therapies for central nervous system (CNS) disorders in the United States. The company's product pipeline includes AXS-05, a therapeutic for the treatment of major depressive disorder and resistant depression disorders; and that is in the Phase III clinic...
More about AXSM
Track This Portfolio

Track Great Lakes Advisors, LLC Portfolio

Follow Great Lakes Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Great Lakes Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Great Lakes Advisors, LLC with notifications on news.